Oakland, CA, United States of America

Mark Vanderwal

USPTO Granted Patents = 6 

 

Average Co-Inventor Count = 4.5

ph-index = 3

Forward Citations = 30(Granted Patents)


Company Filing History:


Years Active: 2020-2025

Loading Chart...
Loading Chart...
6 patents (USPTO):Explore Patents

Title: Mark Vanderwal: Innovator in Cardiac Research

Introduction

Mark Vanderwal is a prominent inventor based in Oakland, CA, known for his significant contributions to cardiac research. With a total of six patents to his name, Vanderwal has made strides in developing innovative solutions for heart-related conditions.

Latest Patents

His latest patents focus on cardiac sarcomere inhibitors. These patents provide compounds of Formula (I) or a pharmaceutically acceptable salt thereof, wherein R, R, R, R, R, and R are defined within the documentation. Additionally, the patents include a pharmaceutically acceptable composition comprising a compound of Formula (I) and methods for using these compounds effectively.

Career Highlights

Vanderwal's career is marked by his role at Cytokinetics, Inc., where he has been instrumental in advancing research in cardiac health. His work has contributed to the understanding and treatment of various cardiac conditions, showcasing his dedication to improving patient outcomes.

Collaborations

Throughout his career, Vanderwal has collaborated with notable colleagues, including Chihyuan Chuang and Bradley Paul Morgan. These partnerships have fostered a collaborative environment that enhances innovation and research in the field.

Conclusion

Mark Vanderwal's contributions to cardiac research through his patents and collaborations highlight his commitment to advancing medical science. His work continues to pave the way for new treatments and innovations in cardiac health.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…